Toxicity of chloroacetaldehyde is similar in adult and pediatric kidney tubules

被引:18
作者
Dubourg, L [1 ]
Tanière, P [1 ]
Cochat, P [1 ]
Baverel, G [1 ]
Michoudet, C [1 ]
机构
[1] Fac Med RTH Laennec, INSERM, Unite 499, Lab Physiopathol Metab & Renale, F-69372 Lyon 08, France
关键词
ifosfamide; toxicity; chloroacetaldehyde; human kidney tubules; children; adults;
D O I
10.1007/s00467-001-0765-2
中图分类号
R72 [儿科学];
学科分类号
100202 [儿科学];
摘要
The nephrotoxicity of chloroacetaldehyde (CAA), one of the main products of hepatic ifosfamide metabolism, was compared in isolated human pediatric and adult renal tubules. Tubules metabolizing lactate were incubated in the presence of various concentrations of CAA (0.1-0.5 mM). Both at low, clinically relevant (0.2 mM), and at higher concentrations (0.3, 0.4 and 0.5 mM), CAA induced a cellular depletion of thiol compounds, i.e. glutathione, coenzyme A and acetyl-coenzyme A that are involved in CAA detoxication and cellular energy metabolism, respectively. The toxicity to renal cells was clearly observed in the presence of 0.4 and 0.5 mM CAA, which led to a fall of the cellular ATP level, to the accumulation of pyruvate and the inhibition of glucose synthesis from lactate. Inhibition of lactate uptake and an increase in the release of lactate dehydrogenase were observed only in the presence of 0.5 mM CAA. The sensitivity of pediatric tubules to the toxic effects of CAA and the rate of their CAA uptake were not statistically different from those found in adult tubules. It is concluded that an increased susceptibility of pediatric tubules to CAA toxicity cannot be put forward to explain the increased risk for ifosfamide-induced nephrotoxicity in children relative to adults.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 41 条
[1]
LACTATE AND PYRUVATE METABOLISM IN ISOLATED RENAL TUBULES OF NORMAL DOGS [J].
BAVEREL, G ;
BONNARD, M ;
ARMAGNACDECASTANET, ED ;
PELLET, M .
KIDNEY INTERNATIONAL, 1978, 14 (06) :567-575
[2]
BERGMEYER H.U., 1974, METHODS ENZYMATIC AN, P574, DOI DOI 10.1016/B978-0-12-091302-2.50010-4
[3]
BERNT E, 1974, METHOD ENZYMAT AN, V3, P1506
[4]
Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration [J].
Boddy, AV ;
Yule, SM ;
Wyllie, R ;
Price, L ;
Pearson, ADJ ;
Idle, JR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 (02) :147-154
[5]
BODDY AV, 1993, CANCER RES, V53, P3758
[6]
IFOSFAMIDE-INDUCED RENAL TUBULAR DYSFUNCTION AND RICKETS IN CHILDREN WITH WILMS-TUMOR [J].
BURK, CD ;
RESTAINO, I ;
KAPLAN, BS ;
MEADOWS, AT .
JOURNAL OF PEDIATRICS, 1990, 117 (02) :331-335
[7]
HYPERAMINOACIDURIA IDENTIFIES PATIENTS AT RISK OF DEVELOPING RENAL TUBULAR TOXICITY ASSOCIATED WITH IFOSFAMIDE AND PLATINATE CONTAINING REGIMENS [J].
CARON, HN ;
ABELING, N ;
VANGENNIP, A ;
DEKRAKER, J ;
VOUTE, PA .
MEDICAL AND PEDIATRIC ONCOLOGY, 1992, 20 (01) :42-47
[8]
Cerny T., 1989, P 5 EUR C CLIN ONC L, P147
[9]
IFOSFAMIDE MESNA - A REVIEW OF ITS ANTINEOPLASTIC ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN CANCER [J].
DECHANT, KL ;
BROGDEN, RN ;
PILKINGTON, T ;
FAULDS, D .
DRUGS, 1991, 42 (03) :428-467
[10]
Dubourg L, 2001, J AM SOC NEPHROL, V12, P1615, DOI 10.1681/ASN.V1281615